In vivo experiments utilizing gene silencing to induce microglial activation have revealed increased tau protein phosphorylation in the hippocampus and impaired synaptic integrity, highlighting the significant role of microglial activation-mediated neuroinflammation in the pathological progression of AD [69]. Here, MAPT is linked to Alzheimer disease.